Code | 3300A | ||||||||||
MA number | EU/1/12/795/004 | ||||||||||
Product Form: | tbl flm 30x1x5 mg (blis.Al/Al-jednotl.dávka) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | AstraZeneca AB, Sweden | ||||||||||
Therapeutic Class: | 18 - ANTIDIABETICA (VRÁTANE INZULÍNU) | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | blister Al/Al | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 12.11.2012 |
SmPC + PL: | European Medicines Agency's database |
Dokument: | DHPC SGLT inhibitors-DKA 18 3 2016.pdf |
Dokument: | DHPC SGLT2 inhibitors - Ketoacidosis 06.07.2015.pdf |
Safety feature | Yes |
Data update: | 17.08.2021 |